Sales & Marketing
Interview with Craig Ackerman Reuters at Pharma USA 2026

Biotech is back, with Craig Ackerman

In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.

R&D
Jeffrey Meckler having an interview with Jonah Comstock

Reuters Pharma USA 2024 – Jeffrey Meckler

Most of the exciting work being done right now in cancer immunotherapy is centred on highly targeted approaches that aim to activate only the most necessary immune responses to eliminate a

R&D
Jonah Comstock interviewing Blair McNeill at Reuters Pharma USA

Reuters Pharma USA 2024 – Blair McNeill

In today's era of cell, gene, and tissue therapies, new treatments are truly game-changing, often creating an opportunity for a healthy, normal life for people who previously had no options

Digital
Jonah Comstock interview with Mindy McGrath at Reuters Pharma USA 24

Reuters Pharma USA 2024 – Mindy McGrath

One of the most salient topics in the United States right now in pharma is market access and drug affordability, and one thing that’s driving that topic in this moment are the drug pricing

Sales & Marketing

Sales & Marketing
Interview with Craig Ackerman Reuters at Pharma USA 2026

Biotech is back, with Craig Ackerman

In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.

Digital

Market Access

Editor's Picks

  1. Novartis snaps up PI3Kα breast cancer drug in $3bn deal
  2. US court says pharma giants must face False Claims suit
  3. Meningitis outbreak in UK prompts call to widen vaccination
  4. US judge rules Kennedy's vaccine changes 'unlawful'
  5. Generic semaglutide in India, and other weight-loss news

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more